Dramatically boosting enrollment of minority populations in clinical trials has become a top goal of the pharmaceutical industry. One way to achieve this is by building a network of clinical trial sites focused on diversity. But stakeholders say there are many hurdles to establishing networks and note the need for partnerships to create community-based infrastructures.
“Existing clinical trial networks have been designed largely to be siloed,” Doug Peddicord, executive director of the Association of Clinical Research Organizations, said
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?